Revista Newslab Edição 179

Referências Bibliográficas
1. Arduino, Francisco. O diabetes ontem e hoje. In:
. Diabetes Mellitus. Rio de Janeiro: Guanabara Koogan.
1980. 414p.
2. Eliaschewitz, Freddy Goldberg (Ed.Cient.). Do papiro
Ebers à descoberta da insulina. Fotógrafo João
Carlos Landi Guimarães. São Paulo: Pfizer, 2006. v.1.
34 p. (A História do Diabetes, 1).
3. Medvei, V.C.. A History of Endocrinology. Lancaster,
England. 1984. 174,175p.
4. BRASIL. Ministério da Saúde. Plano de ações
estratégicas para o enfrentamento das doenças
crônicas não transmissíveis (DCNT) no Brasil, 2011-
2022. Brasília: Ministério da Saúde, 2011a. Disponível
em: . Acesso em: 2 mar. 2017.
5. Ministério da Saúde. Vigitel Brasil 2016: vigilância
de fatores de risco e proteção para doenças crônicas
por inquérito telefônico. Brasília, 2017.
6. Fajans SS, Bell GI. MODY - History, Genetics, Pathophysiology,
and Clinical Decision Making. Diabetes
Care. 2011; 34.
7. Bell GI, Xiang K, Newman MV et al. Gene for non-
-insulin-dependent diabetes mellitus (maturity-
-onset diabetes of the young subtype) is linked to
DNA polymorphism on human chromosome 20q.
Proceedings of the National Academy of Sciences
USA. 1991; 88: 1484-1488.
8. The British Diabetic Association operating as Diabetes
UK. Diabetes. Disponível em: https://www.
diabetes.org.uk/diabetes-the-basics/other-types-
-of-diabetes/mody.
9. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire
M, Sun F, et al. Familial hyperglycemia due to mutations
in glucokinase: definition of a subtype of
diabetes mellitus. N Engl J Med 1993;328:697- 702.
10. Danaei G, Finucane MM, Lu Y, et al., for the Global
Burden of Metabolic Risk Factors of Chronic
Diseases Collaborating Group (Blood Glucose).
National, regional, and global trends in fasting
plasma glucose and diabetes prevalence since
1980: Systematic analysis of health examination
surveys and epidemiological studies with 370
country-years and 2.7 million participants. Lancet.
2011;378:31-40.
11. Thanabalasingham G, Owen KR. Diagnosis and
management of maturity onset diabetes of the
young (MODY). BMJ. 2011;343:d6044.
12. Estalella I, Rica I, Perez de Nanclares G, et al. Mutations
in GCK and HNF-1alpha explain the majority
of cases with clinical diagnosis of MODY in Spain.
Clin Endocrinol (Oxf). 2007;67:538-46.
13. Byrne MM, Sturis J, Menzel S, et al. Altered insulin
secretory responses to glucose in diabetic and
nondiabetic subjects with mutations in the diabetes
susceptibility gene MODY3 on chromosome 12.
Diabetes. 1996;45:1503–1510.
14. Yamagata K, Oda N, Kaisaki PJ, et al. Mutations
in the hepatocyte nuclear factor-1alpha gene in
maturity-onset diabetes of the young (MODY3) Nature.
1996;384:455–458.
15. Colclough K, Bellanne-Chantelot C, Saint-Martin
C, Flanagan SE, Ellard S. Mutations in the genes
encoding the transcription factors hepatocyte nuclear
factor 1 alpha and 4 alpha in maturity-onset
diabetes of the young and hyperinsulinemic hypoglycemia.
Hum Mutat. 2013;34:669–685.
16. Vionnet N, Stoffel M, Takeda J, et al Nonsense
mutation in the glucokinase gene causes early‐onset
non‐insulin‐dependent diabetes mellitus. Nature
1992; 356: 721–722.
17. Shields BM, Hicks S, Shepherd MH, et al Maturity‐onset
diabetes of the young (MODY): how
many cases are we missing? Diabetologia 2010; 53:
2504–2508.
18. Ledermann HM. Is maturity onset diabetes at
young age (MODY) more common in Europe than
previously assumed? Lancet. 1995;345(8950):648.
19. Thanabalasingham G, Owen KR. Diagnosis and
management of maturity onset diabetes of the
young (MODY) BMJ. 2011;343:d6044.
20. Shields BM, Hicks S, Shepherd MH, Colclough K,
Hattersley AT, Ellard S. Maturity-onset diabetes of
the young (MODY): how many cases are we missing?
Diabetologia. 2010;53(12):2504–2508.
21. Colclough K, Saint-Martin C, Timsit J, Ellard S,
Bellanne-Chantelot C. Clinical utility gene card for:
Maturity-onset diabetes of the young. Eur J Hum
Genet. 2014;22(9):E1–E6.
22. Nyunt O, Wu JY, McGown IN, Harris M, Huynh T,
Leong GM, Cowley DM, Cotterill AM. Investigating
maturity onset diabetes of the young. Clin Biochem
Rev. 2009;30:67–74.
23. Vionnet N, Stoffel M, Takeda J, Yasuda K, Bell GI,
Zouali H, Lesage S, Velho G, Iris F, Passa P, Froguel
Ph, Cohen D. Nonsense mutation in the glucokinase
gene causes early-onset non-insulin- dependent
diabetes mellitus. Nature. 1992;356:721–722.
24. Byrne MM, Sturis J, Clément K, Vionnet N,
Pueryo ME, Stoffel M, Takeda J, Passa P, Cohen D,
Bell GI, et al. Insulin secretory abnormalities in subjects
with hyperglycemia due to glucokinase mutations.
J Clin Invest. 1994;93:1120–1130.
25. Byrne MM, Sturis J, Clement K, et al. Insulin
secretory abnormalities in subjects with hyperglycemia
due to glucokinase mutations. J Clin Invest.
1994;93:1120–1130.
26. Naylor RN, Greeley SA, Bell GI, Philipson LH. Genetics
and pathophysiology of neonatal diabetes
mellitus. J Diabetes Investig. 2011;2:158-69.
27. Pontoglio M. Hepatocyte nuclear factor 1, a
transcription factor at the crossroads of glucose
homeostasis. J Am Soc Nephrol. 2000;11 Suppl
1(19):S140–3.
28. Pontoglio M, Barra J, Hadchouel M, Doyen A,
Kress C, Bach JP, et al. Hepatocyte Nuclear Factor
1 Inactivation Results in Hepatic Dysfunction,
Phenylketonuria, and Renal Fanconi Syndrome.
Cell [Internet]. 1996;84(4):575–85. Available from:
http://www.sciencedirect.com/science/article/pii/
S0092867400810338
29. Harries LW, Ellard S, Stride A, Morgan NG, Hattersley
AT. Isomers of the TCF1 gene encoding hepatocyte
nuclear factor-1 alpha show differential
expression in the pancreas and define the relationship
between mutation position and clinical
phenotype in monogenic diabetes. Hum Mol Genet.
2006;15(14):2216–2224. doi: 10.1093/hmg/ddl147.
30. Pearson ER, Starkey BJ, Powell RJ, Gribble FM,
Clark PM, Hattersley AT. Genetic cause of hyperglycaemia
and response to treatment in diabetes.
Lancet. 2003;362:1275-81.
31. Bellanne-Chantelot C, Carette C, Riveline JP,
et al. The type and the position of HNF1A mutation
modulate age at diagnosis of diabetes in patients
with maturity-onset diabetes of the young
(MODY)- 3. Diabetes. 2008;57:503–508.
32. Harries LW, Ellard S, Stride A, Morgan NG, Hattersley
AT. Isomers of the TCF1 gene encoding
hepatocyte nuclear factor-1 alpha show differential
expression in the pancreas and define the relationship
between mutation position and clinical
phenotype in monogenic diabetes. Hum Mol Genet.
2006;15:2216–2224.
33. Harries LW, Locke JM, Shields B, et al. The diabetic
phenotype in HNF4A mutation carriers is
moderated by the expression of HNF4A isoforms
from the P1 promoter during fetal development.
Diabetes. 2008;57:1745–1752.
34. Aas KK, Tambs K, Kise MS, Magnus P, Ronningen
KS. Genetic testing of newborns for type 1 diabetes
susceptibility: a prospective cohort study on effects
on maternal mental health. BMC Med Genet.
2010;11 112-2350-11-112
35. Bell GI, Horita S, Karam JH. A polymorphic locus
near the human insulin gene is associated with
insulin-dependent diabetes mellitus. Diabetes.
1984;33:176–183.
36. Shields BM, Spyer G, Slingerland AS, et al. Mutations
in the glucokinase gene of the fetus result
in reduced placental weight. Diabetes Care.
2008;31:753–757.
37. Bacon S, Schmid J, McCarthy A, et al. The clinical
management of hyperglycemia in pregnancy complicated
by maturity-onset diabetes of the young.
Am J Obstet Gynecol. 2015;213:236.e1– 236.e7.
38. Pettitt DJ, Talton J, Dabelea D, Divers J, Imperatore
G, Lawrence JM, Liese AD, Linder B, Mayer-Davis EJ,
Pihoker C, Saydah SH, Standiford DA, Hamman RF SE-
ARCH for Diabetes in Youth Study Group. Prevalence
of diabetes in U.S. youth in 2009: the SEARCH for diabetes
in youth study. Diabetes Care. 2014;37:402–408.
39. McDonald TJ, Colclough K, Brown R, Shields B,
Shepherd M, Bingley P, Williams A, Hattersley AT,
Ellard S. Islet autoantibodies can discriminate maturity-onset
diabetes of the young (MODY) from
Type 1 diabetes. Diabet Med. 2011;28:1028–1033.
40. Pearson ER, Flechtner I, Njolstad PR, et al. Switching
from insulin to oral sulfonylureas in patients
with diabetes due to Kir6.2 mutations. N Engl J
Med. 2006 Aug 3;355(5):467–77.
41. Shields BM, Hicks S, Shepherd MH, et al. Maturity-onset
diabetes of the young (MODY): how
many cases are we missing? Diabetologia. 2010
Dec;53(12):2504–8.
42. Weinreich SS, Bosma A, Henneman L, et al. A decade
of molecular genetic testing for MODY: a retrospective
study of utilization in The Netherlands.
Eur J Hum Genet. 2015 Jan;23(1):29–33.
43. Yorifuji T, Fujimaru R, Hosokawa Y, et al. Comprehensive
molecular analysis of Japanese patients
with pediatric-onset MODY-type diabetes mellitus.
Pediatr Diabetes. 2012 Feb;13(1):26–32.
44. Furuzawa GK, Giuffrida FM, Oliveira CS, et al.
Low prevalence of MODY2 and MODY3 mutations
in Brazilian individuals with clinical MODY phenotype.
Diabetes Res Clin Pract. 2008 Sep;81(3):e12–4.
45. Mota AJ, Bruggemann S, Costa FF. MODY 2:
mutation identification and molecular ancestry in
a Brazilian family. Gene. 2013 Jan 10;512(2):486–91.
46. Weinert LS, Silveiro SP, Giuffrida FM, et al. Three
unreported glucokinase (GCK) missense mutations
detected in the screening of thirty-two Brazilian
kindreds for GCK and HNF1A-MODY. Diabetes Res
Clin Pract. 2014 Nov;106(2):e44–8.
47. Bonnefond A, Philippe J, Durand E, et al. Highly
sensitive diagnosis of 43 monogenic forms of
diabetes or obesity through one-step PCR-based
enrichment in combination with next-generation
sequencing. Diabetes Care. 2014 Feb;37(2):460–7.
48. Tattersall RB, Fajans SS. A difference between
the inheritance of classical juvenile-onset and maturity-onset
type diabetes of young people. Diabetes.
1975;24(1):44–53.
49. McDonald TJ, Ellard S. Maturity onset diabetes
of the young: identification and diagnosis. Ann Clin
Biochem. 2013;50(Pt 5):403–415.
50. Stanik J, Dusatkova P, Cinek O, Valentinova L,
Huckova M, Skopkova M, Dusatkova L, Stanikova
D, Pura M, Klimes I. et al. De novo mutations of
GCK, HNF1A and HNF4A may be more frequent
in MODY than previously assumed. Diabetologia.
2014;57(3):480–484.
ARTIGO CIENTÍFICO I
Revista NewsLab Edição 179 | Setembro 2023
39